Multiple Clinical Indications of Mifepristone: A Systematic Review

被引:6
|
作者
Mathew, Sharon [1 ]
Ticsa, Maria S. [1 ]
Qadir, Soniya [2 ]
Rezene, Aida [3 ]
Khanna, Deepesh [1 ]
机构
[1] Nova Southeastern Univ, Dr Kiran C Patel Coll Osteopath Med, Fdn Sci, Clearwater, FL 33759 USA
[2] Nova Southeastern Univ, Dr Kiran C Patel Coll Osteopath Med, Med Sch, Clearwater, FL USA
[3] Nova Southeastern Univ, Dr Kiran C Patel Coll Osteopath Med, Osteopath Med, Clearwater, FL USA
关键词
uses of mifepristone; ptsd; psychotic depression; leiomyomas; post-coital contraception; abnormal uterine bleeding; gynecologic and obstetric conditions; abortion pill online; synthetic prostaglandin e1 analog; mifepristone; GLUCOCORTICOID-RECEPTOR ANTAGONIST;
D O I
10.7759/cureus.48372
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Mifepristone and misoprostol are globally used medications that have become disparaged through the stigmatization of reproductive healthcare. Patients are hindered from receiving prompt treatment in clinical scenarios where misoprostol and mifepristone are the drugs of choice. It is no exaggeration to emphasize that in cases where reproductive healthcare is concerned. The aim of this paper is to discuss the different indications of mifepristone and to delineate where the discrepancy in accessibility arises. For this systematic review, we included publications citing clinical trials involving the use and efficacy of mifepristone published in English within the date range of 2000 to 2023. Five databases were searched to identify relevant sources. These databases are Google Scholar, MEDLINE with full text through EBSCO, and three National Center for Biotechnology Information (NCBI) databases (NCBI Bookshelf, PubMed, and PubMed Central). Twenty-three records were ultimately included in this review. Mifepristone has been shown to have therapeutic effects in the treatment of psychiatric disorders, such as major depressive disorder and psychotic depression. There was a significant decrease in depression and psychiatric rating symptoms for patients taking mifepristone versus placebo with no adverse events. Mifepristone has also been shown to improve treatment course in patients with Cushing's disease (CD) who failed or are unable to undergo surgical treatment. In addition, mifepristone has been shown to be a successful treatment option for adenomyosis and leiomyomas. Patients had a statistically significant decrease in uterine volumes following mifepristone treatment, which aided in the alleviation of other symptoms, such as blood loss and pelvic discomfort. Mifepristone is a synthetic steroid that has immense potential to provide symptomatic relief in patients suffering from a wide array of complicated diseases. Historically, mifepristone has been proven to have an incredible safety profile. While further research is certainly needed, the politicization of its medical use for only one of its many indications has unfortunately led to the willful ignorance of its potential despite its evidence-based safety profile and efficacy.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] A systematic scoping review of clinical indications for induction of labour
    Coates, Dominiek
    Makris, Angela
    Catling, Christine
    Henry, Amanda
    Scarf, Vanessa
    Watts, Nicole
    Fox, Deborah
    Thirukumar, Purshaiyna
    Wong, Vincent
    Russell, Hamish
    Homer, Caroline
    PLOS ONE, 2020, 15 (01):
  • [2] Clinical Indications to Germectomy in Pediatric Dentistry: A Systematic Review
    Mazur, Marta
    Ndokaj, Artnora
    Marasca, Beatrice
    Sfasciotti, Gian Luca
    Marasca, Roberto
    Bossu, Maurizio
    Ottolenghi, Livia
    Polimeni, Antonella
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (02)
  • [3] Systematic review of mifepristone for the treatment of uterine leiomyomata
    Steinauer, J
    Pritts, EA
    Jackson, R
    Jacoby, AF
    OBSTETRICS AND GYNECOLOGY, 2004, 103 (06): : 1331 - 1336
  • [4] The clinical utility of exome and genome sequencing across clinical indications: a systematic review
    Salma Shickh
    Chloe Mighton
    Elizabeth Uleryk
    Petros Pechlivanoglou
    Yvonne Bombard
    Human Genetics, 2021, 140 : 1403 - 1416
  • [5] The clinical utility of exome and genome sequencing across clinical indications: a systematic review
    Shickh, Salma
    Mighton, Chloe
    Uleryk, Elizabeth
    Pechlivanoglou, Petros
    Bombard, Yvonne
    HUMAN GENETICS, 2021, 140 (10) : 1403 - 1416
  • [6] A Systematic Review of Indications and Clinical Outcomes of Electrochemotherapy in Pancreatic Ductal Adenocarcinoma
    Rompianesi, Gianluca
    Loiaco, Giuseppe
    Rescigno, Luigi
    Benassai, Gianluca
    Giglio, Mariano Cesare
    Campanile, Silvia
    Caggiano, Marcello
    Montalti, Roberto
    Troisi, Roberto Ivan
    CANCERS, 2025, 17 (03)
  • [7] Reamer-irrigator-aspirator indications and clinical results: a systematic review
    Cox, George
    Jones, Elena
    McGonagle, Dennis
    Giannoudis, Peter V.
    INTERNATIONAL ORTHOPAEDICS, 2011, 35 (07) : 951 - 956
  • [8] In-Office Needle Arthroscopy: A Systematic Review of Indications and Clinical Utility
    Zhang, Kailai
    Crum, Raphael J.
    Samuelsson, Kristian
    Cadet, Edwin
    Ayeni, Olufemi Rolland
    de Sa, Darren
    ARTHROSCOPY-THE JOURNAL OF ARTHROSCOPIC AND RELATED SURGERY, 2019, 35 (09): : 2709 - 2721
  • [9] Reamer-irrigator-aspirator indications and clinical results: a systematic review
    George Cox
    Elena Jones
    Dennis McGonagle
    Peter V. Giannoudis
    International Orthopaedics, 2011, 35 : 951 - 956
  • [10] Clinical indications for carbon-ion radiotherapy in the UK: A systematic review
    Light, Ellie
    Bridge, Pete
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S1905 - S1907